Atlas Trials

Leflunomide in Mild COVID-19 Patients

Clinical trial NCT04361214 · TERMINATED

Trial details

NCT number
NCT04361214
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-05-05
Primary completion
2022-01-31
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.